SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
92 hedge funds and large institutions have $62.4M invested in Sorrento Therapeutics, Inc. in 2020 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 39 increasing their positions, 16 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
92
Holders Change
+4
Holders Change %
+4.55%
% of All Funds
2.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
39
Reduced
16
Closed
14
Calls
$2.28M
Puts
$1.32M
Net Calls
+$960K
Net Calls Change
+$2.14M
Top Buyers
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$1.84M |
| 2 |
Goldman Sachs
New York
|
+$1.49M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$736K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$479K |
| 5 |
JPMorgan Chase & Co
New York
|
+$441K |
Top Sellers
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$1.51M |
| 2 |
D.E. Shaw & Co
New York
|
-$688K |
| 3 |
AMG
Advisors Management Group
La Crosse,
Wisconsin
|
-$669K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$459K |
| 5 |
HF
HRT Financial
New York
|
-$364K |
